LBA75 Prospective randomised phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer: Results of the SUNNIFORECAST trial.
Saved in:
| Title: | LBA75 Prospective randomised phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer: Results of the SUNNIFORECAST trial. |
|---|---|
| Authors: | Bergmann, L.1 (AUTHOR), Ahrens, M.2 (AUTHOR), Albiges, L.3 (AUTHOR), Gross Goupil, M.4 (AUTHOR), Boleti, E.5 (AUTHOR), Gravis, G.6 (AUTHOR), Flechon, A.7 (AUTHOR), Grimm, M-O.J.8 (AUTHOR), Rausch, S.9 (AUTHOR), Barthelemy, P.10 (AUTHOR), Castellano Gauna, D.E.11 (AUTHOR), Mellado Gonzalez, B.12 (AUTHOR), Ivanyi, P.13 (AUTHOR), Floercken, A.14 (AUTHOR), Suarez Rodriguez, C.15 (AUTHOR), Maroto Rey, J.P.16 (AUTHOR), Gruenwald, V.17 (AUTHOR), Burkholder, I.18 (AUTHOR), Hartmann, A.19 (AUTHOR), Haanen, J.B.A.G.20 (AUTHOR) |
| Source: | Annals of Oncology. 2024 Supplement 2, Vol. 35, pS1263-S1263. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
